Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery
线粒体蛋白质折叠机制的结构和机制研究
基本信息
- 批准号:8839001
- 负责人:
- 金额:$ 38.07万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-03-01 至 2019-02-28
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAgingAlzheimer&aposs DiseaseAntineoplastic AgentsApoptosisAtherosclerosisBindingBiochemicalCardiovascular DiseasesCell SurvivalCellsCervix carcinomaClientColon CarcinomaColorectal CancerComplexDevelopmentDiseaseDown-RegulationDrug TargetingFunctional disorderGoalsHandHomeostasisHomologous GeneHumanHuntington DiseaseHybridsIn VitroLigand BindingLightMalignant Epithelial CellMalignant neoplasm of ovaryMalignant neoplasm of prostateMetabolic DiseasesMethodsMitochondriaMitochondrial MatrixMitochondrial ProteinsMolecularMolecular ChaperonesMonitorNeoplasmsNeurodegenerative DisordersNon-Insulin-Dependent Diabetes MellitusNuclearNucleotidesOrganellesParkinson DiseasePeptide HydrolasesPhysiological ProcessesPopulationProcessProliferatingProteinsPublic HealthQuality ControlResearchResolutionRoleSTAT3 geneSignal TransductionStagingStructureSubstrate InteractionSystemTestingTime Factorsage relatedbasecancer cellcancer typecell typechaperone machinerydrug developmentgambogic acidhuman diseasein vivoinhibitor/antagonistinnovationinterestmalignant breast neoplasmmembermitochondrial dysfunctionmortalinmortalitymutantneoplastic cellnovel therapeuticsosteosarcomaparalogous genepreventprostate cancer cellprotein aggregationprotein foldingprotein misfoldingpublic health relevancesmall moleculesurveillance strategythree dimensional structuretranscription factortumor
项目摘要
DESCRIPTION (provided by applicant): Mitochondrial degeneration and dysfunction are a hallmark of aging and aging-related human diseases, including Alzheimer disease, Parkinson disease, Huntington disease, cancer, type 2 diabetes, atherosclerosis, and cardiovascular diseases. Consequently, mitochondria have evolved several surveillance strategies to protect the organelle from damage. At the same time, factors that target mitochondrial proteins and selectively induce apoptosis, for instance of cancer cells, are actively sought after. The mitochondria provide a paradigm to elucidate the network of molecular chaperones and energy-dependent proteases, which function synergistically to maintain protein homeostasis in the mitochondrial matrix. It is widely appreciated that molecular chaperones provide the first line of defense against protein misfolding diseases by promoting folding and preventing aberrant folding and protein aggregation. In addition to their role in protein folding, mitochondrial chaperones, such as Mortalin (mtHsp70) and TRAP1 (mtHsp90) are also widely expressed in most tumor cell types, including colorectal, breast, prostate, and ovarian cancer, which have the highest mortality rates, but strikingly not in highly proliferating, non-tumor cells. Remarkably, down- regulation of TRAP1 abrogates the transforming potential of osteosarcoma, colon carcinoma, and cervix carcinoma cells, supporting a new role of mitochondrial chaperones in the immortalization of cancer cells. Consistently, inhibition of TRAP1 induces apoptosis in prostate cancer cells, underscoring the significance of mitochondrial chaperones as promising new drug targets. The broad and long-term research objective is to provide a molecular understanding of the mitochondrial protein quality control system in vitro and in vivo, to determine the underlying cooperative mechanism and function of the mitochondrial protein folding machinery in normal and pathological states, and how small molecules can be used to modulate mitochondrial chaperone function. The goals of this research will be pursued through the following specific aims: 1) to characterize the mitochondrial protein folding machinery in normal and disease states; 2) to target the structure of TRAP1 with small molecule compounds to modulate its chaperone function; and 3) to determine the structural and molecular basis of TRAP1-substrate interaction. To accomplish our research objective, we will use a multi-pronged in vitro and in vivo approach, which spans different resolution scales and adds to the innovation of the proposed research.
描述(申请人提供):线粒体退化和功能障碍是衰老和与衰老相关的人类疾病的标志,包括阿尔茨海默病、帕金森病、亨廷顿病、癌症、2型糖尿病、动脉粥样硬化和心血管疾病。因此,线粒体演变了几种监视策略来保护细胞器免受损害。与此同时,以线粒体蛋白为靶点并选择性地诱导细胞凋亡的因子,例如癌细胞,正受到积极追捧。线粒体提供了一个范例来阐明分子伴侣和能量依赖的蛋白酶网络,它们协同作用维持线粒体基质中的蛋白质动态平衡。人们普遍认识到,分子伴侣通过促进折叠,防止异常折叠和蛋白质聚集,为蛋白质错误折叠疾病提供了第一道防线。除了在蛋白质折叠中的作用外,线粒体伴侣蛋白,如Mortalin(MtHsp70)和TRAP1(MtHsp90)也广泛表达于大多数肿瘤细胞类型,包括结直肠癌、乳腺癌、前列腺癌和卵巢癌,这些肿瘤细胞的死亡率最高,但令人惊讶的是,在高增殖的非肿瘤细胞中不表达。值得注意的是,TRAP1的下调取消了骨肉瘤、结肠癌和宫颈癌细胞的转化潜力,支持了线粒体伴侣在癌细胞永生化中的新作用。一直以来,抑制TRAP1诱导前列腺癌细胞凋亡,强调了线粒体伴侣作为有希望的新药靶点的重要性。其广泛和长期的研究目标是提供对体外和体内线粒体蛋白质质量控制系统的分子理解,确定线粒体蛋白质折叠机制在正常和病理状态下的潜在合作机制和功能,以及如何利用小分子来调节线粒体伴侣功能。本研究的目标包括:1)研究正常和疾病状态下线粒体蛋白质折叠机制;2)利用小分子化合物靶向TRAP1的结构以调节其伴侣功能;3)确定TRAP1-底物相互作用的结构和分子基础。为了实现我们的研究目标,我们将使用体外和体内多管齐下的方法,这种方法跨越不同的分辨率尺度,增加了拟议研究的创新性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Francis T.F. Tsai其他文献
Three-Dimensional Structure of a Membrane-Anchored AAA Machine
- DOI:
10.1016/j.bpj.2010.12.2270 - 发表时间:
2011-02-02 - 期刊:
- 影响因子:
- 作者:
Sukyeong Lee;Steffen Augustin;Takashi Tatsuta;Florian Gerdes;Thomas Langer;Francis T.F. Tsai - 通讯作者:
Francis T.F. Tsai
Francis T.F. Tsai的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Francis T.F. Tsai', 18)}}的其他基金
Structure, Function, and Mechanism of a Mitochondrial Chaperone
线粒体伴侣的结构、功能和机制
- 批准号:
10493261 - 财政年份:2021
- 资助金额:
$ 38.07万 - 项目类别:
Structure, Function, and Mechanism of a Mitochondrial Chaperone
线粒体伴侣的结构、功能和机制
- 批准号:
10663341 - 财政年份:2021
- 资助金额:
$ 38.07万 - 项目类别:
Structure, Function, and Mechanism of a Mitochondrial Chaperone
线粒体伴侣的结构、功能和机制
- 批准号:
10316887 - 财政年份:2021
- 资助金额:
$ 38.07万 - 项目类别:
Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery
线粒体蛋白质折叠机制的结构和机制研究
- 批准号:
9220839 - 财政年份:2015
- 资助金额:
$ 38.07万 - 项目类别:
Structural and Mechanistic Studies of the Mitochondrial Protein Folding Machinery
线粒体蛋白质折叠机制的结构和机制研究
- 批准号:
9024577 - 财政年份:2015
- 资助金额:
$ 38.07万 - 项目类别:
Structure and Mechanism of a Prion-remodeling Factor
朊病毒重塑因子的结构和机制
- 批准号:
8531529 - 财政年份:2013
- 资助金额:
$ 38.07万 - 项目类别:
Structure and Mechanism of a Prion-remodeling Factor
朊病毒重塑因子的结构和机制
- 批准号:
8670000 - 财政年份:2013
- 资助金额:
$ 38.07万 - 项目类别:
Structure/Mechanism of a Prion-remodeling Factor
朊病毒重塑因子的结构/机制
- 批准号:
7794934 - 财政年份:2008
- 资助金额:
$ 38.07万 - 项目类别:
相似海外基金
Interplay between Aging and Tubulin Posttranslational Modifications
衰老与微管蛋白翻译后修饰之间的相互作用
- 批准号:
24K18114 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Operating Grants
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
- 批准号:
10089306 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Collaborative R&D
Baycrest Academy for Research and Education Summer Program in Aging (SPA): Strengthening research competencies, cultivating empathy, building interprofessional networks and skills, and fostering innovation among the next generation of healthcare workers t
Baycrest Academy for Research and Education Summer Program in Aging (SPA):加强研究能力,培养同理心,建立跨专业网络和技能,并促进下一代医疗保健工作者的创新
- 批准号:
498310 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Operating Grants
関節リウマチ患者のSuccessful Agingに向けたフレイル予防対策の構築
类风湿性关节炎患者成功老龄化的衰弱预防措施的建立
- 批准号:
23K20339 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Life course pathways in healthy aging and wellbeing
健康老龄化和福祉的生命历程路径
- 批准号:
2740736 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Studentship
I-Corps: Aging in Place with Artificial Intelligence-Powered Augmented Reality
I-Corps:利用人工智能驱动的增强现实实现原地老龄化
- 批准号:
2406592 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Standard Grant
NSF PRFB FY 2023: Connecting physiological and cellular aging to individual quality in a long-lived free-living mammal.
NSF PRFB 2023 财年:将生理和细胞衰老与长寿自由生活哺乳动物的个体质量联系起来。
- 批准号:
2305890 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Fellowship Award
虚弱高齢者のSuccessful Agingを支える地域課題分析指標と手法の確立
建立区域问题分析指标和方法,支持体弱老年人成功老龄化
- 批准号:
23K20355 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
「ケア期間」に着目したbiological aging指標の開発
开发聚焦“护理期”的生物衰老指数
- 批准号:
23K24782 - 财政年份:2024
- 资助金额:
$ 38.07万 - 项目类别:
Grant-in-Aid for Scientific Research (B)